Reuters logo
BRIEF-Sensorion gets EU authorization to initiate phase II trial of SENS-111
March 9, 2017 / 4:59 PM / in 7 months

BRIEF-Sensorion gets EU authorization to initiate phase II trial of SENS-111

March 9 (Reuters) - Sensorion SA:

* Sensorion receives European authorization to initiate phase II clinical trial of SENS-111 to treat acute vertigo

* VHP enables Sensorion to conduct its phase II clinical trial in all European Union countries

* Protocol valid via voluntary harmonization procedure

* Patient enrollment is scheduled to begin during Q1 of 2017 Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below